News

Print This Page Bookmark this Page Email this Page

News Releases 2005

FzioMed Submits Third PMA Module to The U.S. Food & Drug Administration for Oxiplex/SP Spine Gel

December 12, 2005 Read Now

FzioMed Announces Publication in Fertility & Sterility Journal of Positive Clinical Results from Oxiplex/AP U.S. Trial in Adhesion Prevention

November 28, 2005 Read Now

FzioMed Receives NIH Grant to Study Injectable Delivery of Bone Growth Peptides for Spinal Fusion

November 15, 2005 Read Now

FzioMed Announces Exclusive, Worldwide License for Bone Growth Peptide Portfolio

November 10, 2005 Read Now

FzioMed Appoints Ron Ehmsen as Vice President of Clinical Affairs

October 19, 2005 Read Now

FzioMed Presents Preclinical Studies of Oxiplex Gel for Drug Delivery, Including Results of Novel Bone Growth Factor

September 28, 2005 Read Now

FzioMed Announces Positive Clinical Results Using Oxiplex/AP to Prevent Post-Surgical Adhesions in Endometriosis Patients

September 14, 2005 Read Now

FzioMed Granted Patent Expanding Oxiplex ® Technology in Drug Delivery and Hemostasis

August 11, 2005 Read Now

FzioMed Appoints John S. Krelle as President and Chief Operating Officer

July 19, 2005 Read Now

FzioMed Reports Promising Results of Novel Bone Growth Factor in Preclinical Studies and Demonstrates Oxiplex Gel as Effective Drug Delivery Platform

July 06, 2005 Read Now

FzioMed and Ethicon Sign Exclusive Distribution Agreement for Adhesion Barrier Product

June 16, 2005 Read Now

FzioMed Awarded New U.S. Patent For Oxiplex® Biomaterial Technology

April 11, 2005 Read Now

Additional News Releases

2017
2015
2014
2013
2012
2011
2010
2008
2007
2006
2004
2003
2002
2001
2000